Omalizumab (Xolair) Lyophilized Powder from Japan
Omalizumab (Xolair) is a humanized monoclonal antibody that binds IgE, used for treating severe asthma. It is presented as a lyophilized powder in measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This biotech product regulates immunological processes in allergic responses.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the lyophilized powder is in retail packaging with measured doses
• Provide batch records and certificates of analysis for customs
• Verify if a Drug Identification Number is required by Health Canada